Skip to main content

Table 2 Demographic and Clinical Data for all Participants (N = 41)

From: Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer

 

Number

Percent (%)

Age, years, mean (SD)

41

59.0 (11.5)

Race

  

 White

35

85.4

 Other

5

12.2

 Missing

1

2.4

Disease Status

  

 Primary

39

95.1

 Recurrence

2

4.9

Stage

  

 IC (recurrence)

1

2.4

 IIA (recurrence)

1

2.4

 IIIA

10

24.4

 IIIC

21

51.2

 IVA

1

2.4

 IVB

7

17

Grade

  

 1

7

17.1

 2

17

41.5

 3

17

41.5

Histology

  

 Endometrioid

32

78.1

 Serous

4

9.8

 Mucinous

1

2.4

 Adeno Squamous

3

7.3

 Endometrioid + Serous

1

2.4

Surgery Type

  

 Open

32

84.2

 Minimally Invasive

6

15.8

Missing

3

 

Extent of lymphadenectomy

  

 Any lymphadenectomy

36

92.3

 Pelvic lymphadenectomy

5

13.9

 Para-aortic lymphadenectomy

1

2.8

 Both

30

83.3